Singleton Legislation to Expand Prostate Cancer Screening Coverage Advances in State Senate
TRENTON, NJ — The New Jersey State Senate has moved forward legislation that would expand health insurance coverage for prostate cancer screenings.
The Senate Commerce Committee on Monday advanced S-1796, sponsored by Senators Troy Singleton and Brian Stack, that would require health insurers to cover an annual prostate cancer screening in accordance with the latest nationally recognized clinical practice guidelines, ensuring that screening recommendations evolve alongside the most current medical evidence.
“Early detection can make all the difference when it comes to successfully treating prostate cancer,” said Singleton (D-Burlington), who represents Bordentown in the Legislature. “By eliminating financial barriers to screening and ensuring that coverage aligns with the most up-to-date clinical guidelines, we can help more men receive timely diagnoses and lifesaving treatment.”
Under the legislation, prostate cancer screenings would be covered without deductibles, co-payments, coinsurance, or other cost-sharing requirements. The bill applies broadly across health insurance markets, including individual and group plans, hospital and medical service corporations, health maintenance organizations, and plans offered through the State Health Benefits Program and the School Employees’ Health Benefits Program. The legislation also ensures that coverage requirements extend to high-deductible health plans to the maximum extent permitted under federal law, while preserving eligibility for health savings accounts and medical savings accounts.
“Prostate cancer remains one of the most common cancers, affecting one in eight men during their lifetime,” said Senator Brian Stack (D-Hudson). “When detected early, it is often highly treatable. Ensuring that screening is covered without out-of-pocket costs and guided by the latest medical standards will help more men get tested and detect the disease earlier, when treatment is most effective.”
Nine states and the District of Columbia have enacted similar laws eliminating cost-sharing requirements for prostate cancer screening services.